| Product Name |
Bendamustine Inhouse Impurity 13 / 4-(5-((2-((4-(5-((2-chloroethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Heterocycles, Pharmaceutical Standards, Fine Chemicals, Amines |
| CAS No |
1219709-87-1 |
| Catalog Number |
GS.07.BND.43 |
| Chemical Name/Synonyms |
4-(5-((2-((4-(5-((2-chloroethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid |
| Molecular Weight |
643.190 |
| Molecular Formula |
C32H43ClN6O6 |
| Purity |
NLT 95% |
| Applications |
4-(5-((2-((4-(5-((2-chloroethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid is widely prescribed to treat hematologic malignancies, such as chronic. |
| Inventory Status |
customized
|
